rs104894566
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000151.4(G6PC1):āc.229T>Cā(p.Trp77Arg) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000617 in 1,458,818 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (ā ā ).
Frequency
Consequence
NM_000151.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
G6PC1 | NM_000151.4 | c.229T>C | p.Trp77Arg | missense_variant, splice_region_variant | 1/5 | ENST00000253801.7 | NP_000142.2 | |
G6PC1 | NM_001270397.2 | c.229T>C | p.Trp77Arg | missense_variant, splice_region_variant | 1/5 | NP_001257326.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
G6PC1 | ENST00000253801.7 | c.229T>C | p.Trp77Arg | missense_variant, splice_region_variant | 1/5 | 1 | NM_000151.4 | ENSP00000253801 | P1 | |
G6PC1 | ENST00000592383.5 | c.229T>C | p.Trp77Arg | missense_variant, splice_region_variant | 1/5 | 2 | ENSP00000465958 | |||
G6PC1 | ENST00000585489.1 | c.229T>C | p.Trp77Arg | missense_variant, splice_region_variant | 1/4 | 5 | ENSP00000466202 | |||
G6PC1 | ENST00000588481.1 | n.294T>C | splice_region_variant, non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000617 AC: 9AN: 1458818Hom.: 0 Cov.: 30 AF XY: 0.00000964 AC XY: 7AN XY: 725922
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA Pathogenic:5
Pathogenic, no assertion criteria provided | literature only | OMIM | May 01, 1996 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Mar 17, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 02, 2021 | Variant summary: G6PC c.229T>C (p.Trp77Arg) results in a non-conservative amino acid change located in the phosphatidic acid phosphate type 2/haloperoxidase domain (IPR000326) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251312 control chromosomes. c.229T>C has been reported in the literature in multiple individuals affected with Glycogen Storage Disease Type Ia (example, Chevalier-Porst_1996, Terzioglu_2001, Miltenberger-Miltenyi_2005, Eminoglu_2013, Quackenbush_2018). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in <10% of normal G6P'ase enzyme activity in vitro in an experimental system of COS-7 cells transfected with mutant constructs (example, Bruni_1999). One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Nov 19, 2021 | NM_000151.3(G6PC1):c.229T>C(W77R) is a missense variant classified as pathogenic in the context of glycogen storage disease type Ia. W77R has been observed in cases with relevant disease (PMID: 8733042, 11916325, 16435186, 23352793, 29374762). Functional assessments of this variant are available in the literature (PMID: 10738525, 11739393). W77R has not been observed in population frequency databases. In summary, NM_000151.3(G6PC1):c.229T>C(W77R) is a missense variant that has functional support for pathogenicity and has been observed more frequently in cases with the relevant disease than in healthy populations. Please note: this variant was assessed in the context of healthy population screening. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 17, 2023 | This sequence change replaces tryptophan, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 77 of the G6PC protein (p.Trp77Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with GSD1a (PMID: 11916325, 16435186, 23352793, 29374762). ClinVar contains an entry for this variant (Variation ID: 12001). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects G6PC function (PMID: 10738525, 11739393). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at